The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells (Q39397567)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells |
scientific article |
Statements
1 reference
The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells (English)
1 reference
Jun Fujiwara
1 reference
Yoshihiro Sowa
1 reference
Mano Horinaka
1 reference
Makoto Koyama
1 reference
Miki Wakada
1 reference
Tsuneharu Miki
1 reference
Toshiyuki Sakai
1 reference
2 February 2012
1 reference
1 reference
40
1 reference
5
1 reference
1483-1491
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference